We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$654M
AUM Growth
-$429K
Cap. Flow
+$9.11M
Cap. Flow %
1.39%
Top 10 Hldgs %
28.74%
Holding
179
New
14
Increased
76
Reduced
66
Closed
5

Top Buys

Rank Stock Value
1
DEO icon
Diageo
DEO
+$8.33M
2
PX
Praxair Inc
PX
+$3.86M
3
TRMB icon
Trimble
TRMB
+$2.57M
4
HDP
Hortonworks, Inc.
HDP
+$1.33M
5
UL icon
Unilever
UL
+$1.27M

Top Sells

Rank Stock Value
1
APD icon
Air Products & Chemicals
APD
+$2.42M
2
PLL
PALL CORP
PLL
+$1.78M
3
AMGN icon
Amgen
AMGN
+$1.42M
4
DD icon
DuPont de Nemours
DD
+$1.42M
5
SEE
Sealed Air
SEE
+$1M

Sector Composition

Rank Sector Weight
1 Technology 20.22%
2 Healthcare 17.34%
3 Industrials 11.1%
4 Energy 11.1%
5 Consumer Staples 10.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXN icon
126
Texas Instruments
TXN
$248B
$395K 0.06%
7,671
-13
-0.2% -$717
CSCO icon
127
Cisco
CSCO
$443B
$388K 0.06%
+14,142
New +$406K
POPE
128
DELISTED
Pope Resources Depositary Receipts of Limited Partnership Units
POPE
$386K 0.06%
5,500
WOLF icon
129
Wolfspeed
WOLF
$1.04B
$375K 0.06%
14,420
-7,325
-34% -$230K
EPD icon
130
Enterprise Products Partners
EPD
$83.7B
$369K 0.06%
12,346
ESRX
131
DELISTED
Express Scripts Holding Company
ESRX
$369K 0.06%
4,154
+14
+0.3% +$1.22K
REGN icon
132
Regeneron Pharmaceuticals
REGN
$72.9B
$357K 0.05%
699
-43
-6% -$21K
DUK icon
133
Duke Energy
DUK
$101B
$350K 0.05%
4,953
+264
+6% +$20K
BMRN icon
134
BioMarin Pharmaceuticals
BMRN
$11.9B
$344K 0.05%
2,512
-196
-7% -$24.3K
SYT
135
DELISTED
Syngenta Ag
SYT
$341K 0.05%
4,181
-100
-2% -$8.04K
VRTX icon
136
Vertex Pharmaceuticals
VRTX
$123B
$336K 0.05%
2,721
-86
-3% -$10.8K
SIAL
137
DELISTED
SIGMA - ALDRICH CORP
SIAL
$312K 0.05%
2,238
+38
+2% +$5.28K
VGK icon
138
Vanguard FTSE Europe ETF
VGK
$30.1B
$311K 0.05%
+5,762
New +$326K
FCX icon
139
Freeport-McMoran
FCX
$86.2B
$309K 0.05%
16,586
-58
-0.3% -$1.2K
HUB.B
140
DELISTED
HUBBELL INC CL-B
HUB.B
$309K 0.05%
2,855
BA icon
141
Boeing
BA
$169B
$308K 0.05%
+2,223
New +$324K
CPB icon
142
Campbell Soup
CPB
$6.85B
$306K 0.05%
6,417
+300
+5% +$14K
GPC icon
143
Genuine Parts
GPC
$17.9B
$303K 0.05%
3,387
+25
+0.7% +$2.3K
ORCL icon
144
Oracle
ORCL
$339B
$295K 0.05%
7,312
+572
+8% +$24.8K
ISRG icon
145
Intuitive Surgical
ISRG
$127B
$287K 0.04%
5,337
+108
+2% +$6.04K
MWV
146
DELISTED
MEADWESTVACO CORP
MWV
$286K 0.04%
6,053
+150
+3% +$7.36K
EOG icon
147
EOG Resources
EOG
$77.7B
$285K 0.04%
3,260
+20
+0.6% +$1.85K
TWC
148
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$277K 0.04%
1,555
-82
-5% -$13.6K
AME icon
149
Ametek
AME
$53.9B
$266K 0.04%
4,847
MDVN
150
DELISTED
MEDIVATION, INC.
MDVN
$266K 0.04%
4,654
-360
-7% -$22.2K

Similar funds

Grandfield & Dodd's Q2 2015 Portfolio in Review

As of Q2 2015, Grandfield & Dodd held 179 positions worth $654M, down 0.07% from $654M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Grandfield & Dodd's Q2 2015 filing shows 14 new, 76 increased, 66 reduced and 5 closed positions. Its largest new stake was Trimble: 105,080 shares worth $2.46M. The largest sale was Air Products & Chemicals, an estimated $2.42M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q2 2015 buy was Trimble: 105,080 shares worth $2.46M.
  • Grandfield & Dodd added most to Diageo in Q2 2015, an estimated $8.33M increase.
  • Grandfield & Dodd's biggest Q2 2015 reduction was Air Products & Chemicals, cutting an estimated $2.42M.
  • Grandfield & Dodd fully exited Fastenal in Q2 2015, selling an estimated $414K.
  • Grandfield & Dodd's ten largest holdings make up 29% of its $654M portfolio in Q2 2015.
  • Grandfield & Dodd opened 14 new positions and closed 5 in Q2 2015.
  • Grandfield & Dodd's portfolio value fell 0.07% quarter-over-quarter to $654M.

Based on Grandfield & Dodd's 13F filing for Q2 2015, filed 3 Aug 2015.